| ASSET | YEAR | % RETURN |
Archrock (AROC) | 2007 | 14,533,500% |
Danaos (DAC) | 2006 | 3,692,998.33% |
DXP Enterprises (DXPE) | 1997 | 2,874,900% |
Asbury Automotive (ABG) | 2002 | 2,530,000% |
Northern Oil & Gas (NOG) | 2007 | 2,244,612.5% |
Green Brick Partners (GRBK) | 2007 | 1,799,419.61% |
Eldorado Gold (EGO) | 2003 | 32,273.73% |
Regencell Bioscience (RGC) | 2025 | 15,606.81% |
Applied Digital (APLD) | 2021 | 11,073.33% |
Argan (AGX) | 1995 | 6,999.68% |
Definium Therapeutics (DFTX) | 2020 | 5,346.43% |
Weatherford International (WFRD) | 2019 | 5,162.8% |
Travere Therapeutics (TVTX) | 2005 | 5,110.53% |
Aurinia Pharmaceuticals (AUPH) | 2013 | 5,088.91% |
Perpetua Resources (PPTA) | 2021 | 4,900% |
Axsome Therapeutics (AXSM) | 2019 | 3,578.29% |
NeoGenomics (NEO) | 2000 | 2,877.14% |
Aura Minerals Inc Common Shares (AUGO) | 2009 | 2,711.03% |
Option Care Health (OPCH) | 2001 | 2,090.77% |
Ondas (ONDS) | 2020 | 1,999.46% |
Par Pacific (PARR) | 2012 | 1,900% |
Abivax SA American Depositary Shares (ABVX) | 2025 | 1,762.64% |
Avis Budget (CAR) | 2009 | 1,747.82% |
InterDigital (IDCC) | 1999 | 1,438.45% |
Rigetti Computing (RGTI) | 2024 | 1,426% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.